Search


Current filters:

Start a new search
Add filters:

Use filters to refine the search results.


Results 41-46 of 46
Item hits:
Issue DateTitleAuthor(s)
19-Oct-2015A putative biomarker signature for clinically effective AKT inhibition: correlation of in vitro, in vivo and clinical data identifies the importance of modulation of the mTORC1 pathwayCheraghchi-Bashi, A; Parker, CA; Curry, E; Salazar, J-F; Gungor, H, et al
7-Jul-2016Integrative analysis of subcellular quantitative proteomics studies reveals functional cytoskeleton membrane–lipid raft interactions in cancerShah, AD; Inder, KL; Shah, AK; Cristino, AS; McKie, AB, et al
2-Oct-2018Anti-tumour activity of a first-in-class agent NUC-1031 in patients with advanced cancer: results of a phase I studyBlagden, SP; Rizzuto, I; Suppiah, P; O'Shea, D; Patel, M, et al
1-Aug-2018Characterisation of tumour microvessel density during progression of high-grade serous ovarian cancer: clinico-pathological impact (an OCTIPS Consortium study)Ruscito, I; Castillo-Tong, DC; Vergote, I; Ignat, I; Stanske, M, et al
30-Jun-2011Integrated genomic analyses of ovarian carcinomaBell, D; Berchuck, A; Birrer, M; Chien, J; Cramer, DW, et al
9-Aug-2017Copy-number signatures and mutational processes in ovarian carcinomaMacintyre, G; Goranova, T; De Silva, D; Ennis, D; Piskorz, A, et al